hotspot -WSS

hotspot

author：Wikipedia 2025-08-11 11:45:44 - browse：4

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： New report analyzes digital physical therapy solutions' effectiveness

leisure time

WSS

European officials brace for rough respiratory virus season

New report analyzes digital physical therapy solutions' effectiveness

STAT Virtual Event: ASCO Recap, Live!

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

The stability of $0 premiums in Medicare Advantage

2023 Nobel Prize in Medicine goes to Karikó and Weissman

hotspot

hotspot

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Lilly's Alzheimer's drug donanemab backed by FDA advisers

In Memoriam: Notable people who died in 2023

The stability of $0 premiums in Medicare Advantage

ChatGPT in medicine: STAT answers readers' burning questions

The stability of $0 premiums in Medicare Advantage

At least 13 dead in Texas as scorching temps continue

Cigna wins case to block Amy Bricker's move to CVS

Dobbs anniversary: the lost opportunity of abortion as health care

Nobel honors Karikó and Weissman's enduring partnership

Wikipedia

5 takeaways from STAT's examination of Zynex Medical

5 takeaways from STAT's examination of Zynex Medical

ALS patient reclaims some autonomy thanks to wearable 'robot'

Statins may not be needed by millions of people, study suggests

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

explore

hotspot

leisure time

hotspot